Novartis India Vice Chairman and Managing Director Jawed Zia resigns
New Delhi: Novartis India said its Vice Chairman and Managing Director Jawed Zia has decided to step down from the post.
"Jawed Zia, Vice Chairman & Managing Director, Novartis India Limited has informed the Board of Directors of his decision to step down from the office of Vice Chairman and Managing Director at the close of business hours on May 31, 2018," the company said in a BSE filing.
The board, the filing said, has requested the nomination and remuneration committee to identify and recommend a suitable successor for the role of Vice Chairman and Managing Director of the company.
In India, the pharmaceutical business of Novartis India Ltd is focused on bone and pain, calcium portfolio, gynaecology, and neuroscience and the generic business is focused on gynaecology, anti-TB, and anti-infectives.
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd